Design Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DSGN and other ETFs, options, and stocks.

About DSGN

Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. 

CEO
Pratik Shah
CEOPratik Shah
Employees
124
Employees124
Headquarters
Carlsbad, California
HeadquartersCarlsbad, California
Founded
2017
Founded2017
Employees
124
Employees124

DSGN Key Statistics

Market cap
219.48M
Market cap219.48M
Price-Earnings ratio
-3.13
Price-Earnings ratio-3.13
Dividend yield
—
Dividend yield—
Average volume
349.63K
Average volume349.63K
High today
$3.90
High today$3.90
Low today
$3.68
Low today$3.68
Open price
$3.79
Open price$3.79
Volume
143.63K
Volume143.63K
52 Week high
$8.47
52 Week high$8.47
52 Week low
$1.94
52 Week low$1.94
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.